Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant is used in females for the prevention of cervical, vulvar and vaginal cancers caused by Human Papillomavirus (HPV). It also prevents pre-cancerous or dysplastic lesions, genital warts and infections caused by HPV in both males and females.

Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant is best given as early as possible in adolescent girls between 11 and 12 years of age. It is also recommended for all teenagers and adults between 13 to 26 years of age who did not get the vaccine when they were younger. Children as young as 9 years old can also receive this when advised by the doctor. The dose and schedule of the vaccine depend on the age of the person. Consult your doctor if you are not sure.

Yes, you can still get the vaccine even if you have had sexual intercourse. There are 100 types of Human Papillomavirus (HPV). Even if you already have one strain of HPV, you can still benefit from the vaccine because it can protect you from other strains that you don't yet have.

No, you can just continue from where you left off. However, it would be best to consult your doctor before using Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant again.

Yes, vaccinated women will still need regular cervical cancer screening as the effect of the vaccine may work against most but not all HPV types that can cause cervical cancer.

Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant works extremely well for most of the cases. Clinical trials have shown that these types of vaccines provide close to 100% protection against cervical and vaginal cancer, genital warts and infection caused by the Human Papillomavirus (HPV) types.

Overall, Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant does not have any major side effects. The most common side effects include soreness, swelling or redness at the injection site. Sometimes dizziness or fainting occurs after the injection, sitting for 15 minutes after the injection can reduce the risk of fainting. One may also experience headaches, nausea, vomiting, fatigue or weakness. Consult your doctor if the symptoms bother you for long.

If your partner has an HPV infection (with or without symptoms), you can still get infected with HPV even if you always use the condom. The reason being that a condom cannot provide 100% protection from any sexually transmitted infection. Further more, HPV is mostly transmitted during sexual intercourse, it can also be transmitted due to oral sex or during genital to genital contact.

Yes, Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant can be given either simultaneously, before or after any other live or inactivated vaccines. However, each time a different syringe and a different site should be used. Studies have shown that administering this vaccine with other vaccines does not have any effect on the antibody response by the body and does not change its effectiveness. However, it is advised to consult the doctor before using any other vaccine.

No, Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant is not a live vaccine. Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant contains virus-like particles produced from the outer protein covering of virus (capsid) of each HPV type using DNA recombinant technology (creating DNA sequences that would not otherwise be found in the gene pool). Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinants do not have any viral DNA and can neither cause an infection nor a cancer.

Research suggests that Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant protection is effective for a very long duration. There is no evidence which indicates decrease in protection over time. Some studies have shown that individuals who were vaccinated were protected for about 12 years. Further studies are ongoing to determine the exact duration of protection.

No, there is no need to get an HPV test or a pap test to find out if they should get the vaccine. However, women should get screened for cervical cancer, even if they have received all the recommended shots of Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant. This is because the Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant does not prevent all types of cancer of the cervix.

The Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant is highly effective in preventing the targeted HPV types. It also protects against the most common health problems caused by them. The vaccine is less effective in preventing HPV-related disease in young women who have already been exposed to one or more types of HPV. This is because the vaccine is only meant for the prevention of HPV related disease, not for the treatment.

Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant is safe and well tolerated among patients. The vaccines usually undergo years of testing before being licensed by the health authorities and remain under continuous monitoring for safety. Side effects with Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant are mild to moderate in intensity and commonly include pain, swelling and redness at the injection site and headache.

The vaccine is recommended to be used in young girls (9-13 years) before they are sexually active, as it is most effective and induces a superior immune response at this age. However, it can be given to women up to 45 years of age. In males, it is recommended to be used at the age of 16-26 years.

Quadrivalent vaccine means that the vaccine protects against 4 types of human papillomavirus. The human papilloma quadrivalent vaccine is effective against diseases caused by HPV types 6, 11, 16 and 18. It prevents various diseases caused by the virus but does not treat them. The diseases may include pre-cancerous lesions of the female genitals, pre-cancerous lesions of the anus and genital warts in males as well as females, cervical and anal cancers.